WI
VRTX icon

Wahed Invest’s Vertex Pharmaceuticals VRTX Stock Holding History

Wahed Invest’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01M Sell
6,050
-365
-6% -$162K 0.31% 45
2026
Q1 		$2.86M Sell
6,415
-356
-5% -$166K 0.37% 45
2025
Q4 		$3.07M Sell
6,771
-29
-0.4% -$12.5K 0.4% 44
2025
Q3 		$2.66M Buy
+6,800
New +$2.84M 0.36% 44
2025
Q2 		– Sell
-6,663
Closed -$3.23M – 236
2025
Q1 		$3.23M Buy
+6,663
New +$3.1M 0.56% 34

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wahed Invest's VRTX Position: Q2 2026 in Review

Wahed Invest reduced its Vertex Pharmaceuticals (VRTX) stake by 5.7% in Q2 2026, selling an estimated $162K and leaving 6,050 shares worth $3.01M. The position accounts for 0.31% of the portfolio, ranked #45.

Wahed Invest first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.23M in Q1 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Wahed Invest held 6,050 shares of Vertex Pharmaceuticals worth $3.01M as of Q2 2026.
  • Wahed Invest sold 365 Vertex Pharmaceuticals shares in Q2 2026, an estimated $162K.
  • Vertex Pharmaceuticals made up 0.31% of Wahed Invest's portfolio in Q2 2026, its #45 holding.
  • Wahed Invest first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Wahed Invest's Vertex Pharmaceuticals position peaked at $3.23M in Q1 2025.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Wahed Invest's 13F filing for Q2 2026, filed 11 Aug 2026.